Search by property

This page provides a simple browsing interface for finding entities described by a property and a named value. Other available search interfaces include the page property search, and the ask query builder.

List of results

• Reference:EU Regulation (EU) 910/2014 - electronic identification 17-Sep-2014 -  + (TAG-00286-Ele-sch ++ TAG-00149-Sig-nds)
• Reference:GBR The Electronic Identification and Trust Services for Electronic Transactions (Amendment etc.) (EU Exit) Regulations 2019 23-Jan-2019 -  + (TAG-00286-Ele-sch ++ TAG-00149-Sig-nds ++ TAG-00340-Req-nfo)
• Reference:EU EMA/INS/GCP/112288/2023 - Guideline on computerised systems and electronic data in clinical trials 2023 4.8  + (TAG-00286-Ele-sch ++ TAG-00149-Sig-nds ++ TAG-00340-Req-nfo ++ TAG-00165-Sys-omb)
• Reference:USA 21 CFR Part 11 09-Apr-2025 § 11.3 (b) (5) ; (b) (7) ; (b) (8)  + (TAG-00286-Ele-sch ++ TAG-00149-Sig-nds ++ TAG-00244-Def-ini ++ TAG-00320-Foo-eri)
• Reference:USA 21 CFR Part 11 09-Apr-2025 § 11.70  + (TAG-00286-Ele-sch ++ TAG-00149-Sig-nds ++ TAG-00064-Ele-eUn ++ TAG-00129-Dat-ali)
• Reference:USA 21 CFR Part 11 09-Apr-2025 § 11.200  + (TAG-00286-Ele-sch ++ TAG-00165-Sys-omb ++ TAG-00320-Foo-eri)
• Reference:GBR The Medicines for Human Use (Clinical Trials) Regulations 2004 01-May-2004 Part 1 Article 2  + (TAG-00286-Ele-sch ++ TAG-00244-Def-ini)
• Reference:EU Regulation (EU) 910/2014 - electronic identification 17-Sep-2014 Article 3 Paragraph 10  + (TAG-00286-Ele-sch ++ TAG-00244-Def-ini)
• Reference:USA 21 CFR Part 11 09-Apr-2025 § 11.300  + (TAG-00286-Ele-sch ++ TAG-00294-Rem-gFe ++ TAG-00165-Sys-omb)
• Reference:USA 21 CFR Part 11 09-Apr-2025 § 11.50  + (TAG-00286-Ele-sch ++ TAG-00340-Req-nfo ++ TAG-00064-Ele-eUn)
• Reference:USA 21 CFR Part 11 09-Apr-2025 § 11.100  + (TAG-00286-Ele-sch ++ TAG-00340-Req-nfo ++ TAG-00320-Foo-eri)
• Reference:ICH ICH E6 Guideline R3 (2025) Appendix B 4.8-001  + (TAG-00287-Sto-pre ++ TAG-00033-Pro-oto ++ TAG-00055-Stu-ngs)
• Reference:ICH ICH E6 Guideline R3 (2025) Appendix B 4.8-002  + (TAG-00287-Sto-pre ++ TAG-00033-Pro-oto ++ TAG-00055-Stu-ngs)
• Reference:WHO WHO - Guidance for best practices for clinical trials 2024 2.5  + (TAG-00288-Qua-nag ++ TAG-00055-Stu-ngs ++ TAG-00144-Qua-gew)
• Reference:EU Recommendations of the expert group - Risk proportionate approaches in clinical trials 25-Apr-2017 4.1  + (TAG-00289-Ris-Qua ++ TAG-00288-Qua-nag ++ TAG-00176-Ris-erh)
• Reference:EU EMA/298712/2022 - Complex clinical trials – Questions and answers 23-May-2022 Q1.2  + (TAG-00289-Ris-Qua ++ TAG-00288-Qua-nag ++ TAG-00176-Ris-erh ++ TAG-00008-Cli-ngK)
• Reference:ISO ISO 14155 - Clinical investigation of medical devices for human subjects 2020 10.7 (e)  + (TAG-00292-Eme-ent ++ TAG-00123-Bli-ppe ++ TAG-00031-Pat-onA ++ TAG-00201-Cli-eSt)
• Reference:ICH ICH E9 Guideline 1998 2.3.1  + (TAG-00292-Eme-ent ++ TAG-00314-Unb-ung ++ TAG-00123-Bli-ppe ++ TAG-00062-Med-tre)
• Reference:DEU Empfehlungen des BfArM und des PEI zur Europäischen Guidance during COVID-19 v4 04-Feb-2021 -  + (TAG-00295-Rem-erp ++ TAG-00065-Sou-nüb ++ TAG-00322-Fed-imi ++ TAG-00323-Pau-Imp ++ TAG-00029-Inf-rte)
• Reference:EU GUIDANCE ON THE MANAGEMENT OF CLINICAL TRIALS DURING THE COVID-19 (CORONAVIRUS) PANDEMIC v5 10-Feb-2022 Annex 1  + (TAG-00295-Rem-erp ++ TAG-00065-Sou-nüb ++ TAG-00025-Sub-mer ++ TAG-00334-Tra-ngP ++ TAG-00176-Ris-erh)
• Reference:AUT FAQ - COVID-19 Studien 15-Mar-2021 -  + (TAG-00295-Rem-erp ++ TAG-00065-Sou-nüb ++ TAG-00326-Fed-wes ++ TAG-00150-Sou-eUr)
• Reference:EU GUIDANCE ON THE MANAGEMENT OF CLINICAL TRIALS DURING THE COVID-19 (CORONAVIRUS) PANDEMIC v5 10-Feb-2022 11 d)  + (TAG-00295-Rem-erp ++ TAG-00065-Sou-nüb ++ TAG-00138-Rem-oni ++ TAG-00329-Saf-lne ++ TAG-00025-Sub-mer)
• Reference:GBR Making changes to a research study to manage the impact of COVID-19 12-Oct-2021 -  + (TAG-00295-Rem-erp ++ TAG-00138-Rem-oni ++ TAG-00063-Dat-per ++ TAG-00031-Pat-onA ++ TAG-00017-Spo-die)
• Reference:USA FDA Guidance for Industry - Conduct of Clinical Trials of Medical Products During the COVID-19 Public Health Emergency Mar-2020 Q15  + (TAG-00295-Rem-erp ++ TAG-00138-Rem-oni ++ TAG-00320-Foo-eri ++ TAG-00150-Sou-eUr ++ TAG-00137-Mon-che)
• Reference:FRA Bonnes pratiques - CONTRÔLE QUALITÉ À DISTANCE DES ESSAIS CLINIQUES (CNIL) 16-May-2024 -  + (TAG-00295-Rem-erp ++ TAG-00321-Age-pro ++ TAG-00063-Dat-per ++ TAG-00291-Qua-tsk ++ TAG-00143-Non-abw)

• Reference:ICH ICH E8 Guideline R1 (2021) ANNEX: TYPES OF CLINICAL STUDIES  + (TAG-00301-Cli-eII)

• Reference:WHO WHO - Guidelines for GCP for trials on pharmaceutical products* 1995 Glossary - clinical trial Phases  + (TAG-00301-Cli-eII ++ TAG-00008-Cli-ngK ++ TAG-00279-Hea-rFr)
• Reference:USA 21 CFR Part 312 09-Apr-2025 § 312.21  + (TAG-00301-Cli-eII ++ TAG-00201-Cli-eSt ++ TAG-00011-Inv-tud)
• Reference:USA 21 CFR Part 312 09-Apr-2025 § 312.85  + (TAG-00301-Cli-eII ++ TAG-00320-Foo-eri ++ TAG-00017-Spo-die ++ TAG-00001-Med-rzn)
• Reference:WHO WHO - Guidance for best practices for clinical trials 2024 1.1 - Platform, basket and umbrella trials  + (TAG-00302-Ada-die ++ TAG-00033-Pro-oto ++ TAG-00277-Pla-par ++ TAG-00055-Stu-ngs)
• Reference:EU EMA/298712/2022 - Complex clinical trials – Questions and answers 23-May-2022 Glossary  + (TAG-00302-Ada-die ++ TAG-00033-Pro-oto ++ TAG-00244-Def-ini ++ TAG-00011-Inv-tud)
• Reference:ICH ICH E8 Guideline R1 (2021) 6.1.4  + (TAG-00303-Int-lan ++ TAG-00129-Dat-ali ++ TAG-00123-Bli-ppe ++ TAG-00133-Ind-rhe)
• Reference:ICH ICH E9 Guideline 1998 4.5  + (TAG-00303-Int-lan ++ TAG-00287-Sto-pre ++ TAG-00038-Ear-tig ++ TAG-00329-Saf-lne)
• Reference:DEU DGEPi - GEP Guter Epidemiologischer Praxis Sep-2018 Leitlinie 3 3.7  + (TAG-00306-Dat-nDa ++ TAG-00010-Non-Stu ++ TAG-00343-Doc-ten)
• Reference:WHO WHO - Guidance for best practices for clinical trials 2024 2.1.8  + (TAG-00306-Dat-nDa ++ TAG-00124-Cas-Prü ++ TAG-00025-Sub-mer)
• Reference:DEU DGEPi - GEP Guter Epidemiologischer Praxis Sep-2018 Leitlinie 7  + (TAG-00306-Dat-nDa ++ TAG-00343-Doc-ten ++ TAG-00095-Sto-ung ++ TAG-00010-Non-Stu)
• Reference:EU EMA/INS/GCP/112288/2023 - Guideline on computerised systems and electronic data in clinical trials 2023 Annex 5 A5.2  + (TAG-00307-Int-gsu ++ TAG-00145-Ran-ute ++ TAG-00123-Bli-ppe ++ TAG-00127-Com-meC)
• Reference:ICH ICH E6 Guideline - Annex 2 R3 Annex 2 Annex 2 Introduction  + (TAG-00309-Rea-eal ++ TAG-00129-Dat-ali ++ TAG-00008-Cli-ngK)
• Reference:ICH ICH E6 Guideline R3 (2025) III. Annex 1 2.8.9  + (TAG-00312-Imp-isi ++ TAG-00029-Inf-rte ++ TAG-00030-Inf-onu ++ TAG-00028-Leg-ich)
• Reference:WHO WHO - Guidelines for GCP for trials on pharmaceutical products* 1995 Glossary - witness  + (TAG-00312-Imp-isi ++ TAG-00244-Def-ini ++ TAG-00029-Inf-rte ++ TAG-00149-Sig-nds)
• Reference:ICH ICH E6 Guideline R3 (2025) III. Annex 1 3.16.1 (g)  + (TAG-00314-Unb-ung ++ TAG-00123-Bli-ppe ++ TAG-00129-Dat-ali)
• Reference:ICH ICH E6 Guideline R3 (2025) III. Annex 1 2.9.3  + (TAG-00314-Unb-ung ++ TAG-00123-Bli-ppe ++ TAG-00025-Sub-mer ++ TAG-00246-Inv-hte)
• Reference:WHO WHO - HANDBOOK FOR GOOD CLINICAL RESEARCH PRACTICE (GCP) 2005 Page 31  + (TAG-00314-Unb-ung ++ TAG-00292-Eme-ent ++ TAG-00123-Bli-ppe ++ TAG-00246-Inv-hte)
• Reference:EU Regulation (EU) 536/2014 - clinical trials 05-Dec-2022 ANNEX VI Section 2.5 No. 17-22  + (TAG-00314-Unb-ung ++ TAG-00292-Eme-ent ++ TAG-00048-Sus-ngV ++ TAG-00246-Inv-hte ++ TAG-00329-Saf-lne)
• Reference:USA 21 CFR Part 50 09-Apr-2025 § 50.3 (k)-001  + (TAG-00316-Del-sbe ++ TAG-00052-Ris-ein ++ TAG-00244-Def-ini)
• Reference:USA FD&C Act - Federal Food, Drug, and Cosmetic Act 30-Sep-2023 Sec 512 (f)  + (TAG-00316-Del-sbe ++ TAG-00053-Dev-las ++ TAG-00155-Med-Med)
• Reference:USA FD&C Act - Federal Food, Drug, and Cosmetic Act 30-Sep-2023 Sec 737 (8)  + (TAG-00316-Del-sbe ++ TAG-00053-Dev-las ++ TAG-00244-Def-ini)
• Reference:USA 45 CFR Part 46 09-Apr-2025 § 46.104  + (TAG-00316-Del-sbe ++ TAG-00134-Eth-kom)
• Reference:USA 21 CFR Part 56 09-Apr-2025 § 56.104 (d)  + (TAG-00316-Del-sbe ++ TAG-00134-Eth-kom ++ TAG-00320-Foo-eri)
• Reference:USA U.S. Code Title 21 30-Sep-2023 § 321 (h)  + (TAG-00316-Del-sbe ++ TAG-00155-Med-Med ++ TAG-00244-Def-ini)
• Reference:USA FD&C Act - Federal Food, Drug, and Cosmetic Act 30-Sep-2023 Sec 510 (k)  + (TAG-00316-Del-sbe ++ TAG-00155-Med-Med ++ TAG-00340-Req-nfo)